paclitaxel has been researched along with Cancer of the Retina in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kandalam, M; Krishnakumar, S; Maheswari, UK; Mitra, M; Sundaram, CS; Swaminathan, S; Verma, RS | 1 |
| Harilal, A; Krishnakumar, S; Misra, R; Mitra, M; Sahoo, SK | 1 |
| Feuer, W; Hernandez, E; Jockovich, ME; Murray, TG; Parel, JM; Suárez, F | 1 |
3 other study(ies) available for paclitaxel and Cancer of the Retina
| Article | Year |
|---|---|
Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
Topics: Apoptosis; Blotting, Western; Caspase 3; Cell Cycle; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation; Gene Silencing; Humans; Microtubules; Mitotic Index; Paclitaxel; Poly(ADP-ribose) Polymerases; Retinal Neoplasms; Retinoblastoma; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Stathmin; Transfection; Tubulin Modulators; Tumor Cells, Cultured; Vincristine | 2011 |
Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
Topics: Antibodies; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Adhesion Molecules; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Cross-Linking Reagents; Drug Carriers; Endocytosis; Epithelial Cell Adhesion Molecule; Flow Cytometry; Humans; Immunoconjugates; Lactic Acid; Nanoparticles; Paclitaxel; Particle Size; Poly(ADP-ribose) Polymerases; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Retinal Neoplasms; Retinoblastoma | 2011 |
Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Conjunctiva; Disease Models, Animal; Injections, Intralesional; Linear Models; Luteinizing Hormone, beta Subunit; Mice; Mice, Transgenic; Paclitaxel; Retinal Neoplasms; Retinoblastoma | 2007 |